Journal article
Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial
Jean-Frederic Colombel, William J Sandborn, Paul Rutgeerts, Michael A Kamm, Andrew P Yu, Eric Q Wu, Paul F Pollack, Kathleen G Lomax, Jingdong Chao, Parvez M Mulani
American Journal of Gastroenterology | NATURE PUBLISHING GROUP | Published : 2009
DOI: 10.1038/ajg.2009.59
Grants
Funding Acknowledgements
The CHARM study reported in this paper was supported by research grants from Abbott Laboratories, Abbott Park, IL, USA.